# Compare the Efficacy and Tolerability of the Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitors (SSRIs) Used in Major Depression

> **NCT00873795** · NA · COMPLETED · sponsor: **Chimei Medical Center** · enrollment: 41 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** aripiprazole , sertraline

## Key facts

- **NCT ID:** NCT00873795
- **Lead sponsor:** Chimei Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2009-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00873795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00873795, "Compare the Efficacy and Tolerability of the Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitors (SSRIs) Used in Major Depression". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00873795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*